Updated: April 16, 2026
How to Help Your Patients Save Money on Omnitrope: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Why Omnitrope Cost Is a Common Barrier to Adherence
- Program 1: OmniSource Co-Pay Savings Program — As Low As $0/Month
- Program 2: OmniSource Self-Pay Program — $19/mg
- Program 3: OmniSource Bridge Supply — Up to 1 Year
- Program 4: Novartis Patient Assistance Program — Cost-Free for Eligible Patients
- Program 5: Good Days Patient Assistance — For Insured Patients with Financial Need
- Medicare Part D Patients: Special Considerations
- Recommended Office Workflow for Omnitrope Savings
- How medfinder Reduces Your Practice's Access-Related Phone Volume
- Key Contacts for Omnitrope Patient Support
A provider-focused guide to every Omnitrope savings program available in 2026, including OmniSource co-pay assistance, self-pay rates, patient assistance, and how to help patients enroll.
Omnitrope is one of the most comprehensive savings programs of any growth hormone brand — yet these programs are significantly underutilized because patients and providers alike don't know about them. As a prescriber, your familiarity with Sandoz's OmniSource support infrastructure can directly affect whether your patients stay on therapy or abandon it due to cost. This guide covers every available Omnitrope savings mechanism in 2026 and provides actionable steps for incorporating them into your practice workflow.
Why Omnitrope Cost Is a Common Barrier to Adherence
Without insurance or financial assistance, Omnitrope's retail pricing creates prohibitive out-of-pocket costs:
- 5 mg/1.5 mL cartridge: ~$656 at retail
- 10 mg/1.5 mL cartridge: ~$1,304 at retail
- Monthly treatment costs: $600–$3,000+ depending on dose, weight, and formulation
Even with commercial insurance, specialty tier cost-sharing can result in significant patient out-of-pocket expense, particularly in the deductible phase. These costs directly correlate with non-adherence, especially for pediatric patients whose families bear the financial burden.
Program 1: OmniSource Co-Pay Savings Program — As Low As $0/Month
This is the most impactful program for commercially insured patients with Omnitrope coverage:
- Who qualifies: Commercially insured patients with prescription coverage for Omnitrope
- Benefit: May pay as little as $0 per monthly prescription; insured patients without specific Omnitrope coverage can save up to $417/month
- Restrictions: Cannot be combined with government-funded coverage (Medicare, Medicaid, Tricare). Maximum savings limits may apply.
- Enrollment: Patients register at omnitrope.com/co-pay-savings-program or call 1-866-954-5512. A printable card is available.
Office workflow tip: Print the enrollment QR code or URL and include it in your new Omnitrope patient education packet. Staff can assist patients with enrollment at the office visit.
Program 2: OmniSource Self-Pay Program — $19/mg
This is Sandoz's most comprehensive self-pay option and is suitable for uninsured patients or those whose commercial insurance does not cover Omnitrope:
- Who qualifies: Uninsured patients; commercially insured patients whose insurance does not cover Omnitrope
- Benefit: Omnitrope Pen 5 and Pen 10 available at $19/mg — a dramatic reduction from retail pricing
- Practical example: An adult patient on 0.2 mg/day (1.4 mg/week, ~6 mg/month) would pay approximately $114/month vs. $650+ at retail
- Enrollment: Contact OmniSource at 877-456-6794 or visit omnitrope.com/pro/supporting-your-patient/self-pay-program
Program 3: OmniSource Bridge Supply — Up to 1 Year
This is one of the most underutilized but valuable programs in the growth hormone space:
- Who qualifies: Commercially insured patients whose insurance coverage is delayed or denied and being appealed
- Trigger: Insurance authorization delay of more than 10 business days
- Benefit: Patients can receive free Omnitrope for up to 1 full year as interim treatment assistance
Office workflow tip: Build a PA tracking system. Flag any new PA or appeal that has been outstanding for 8+ business days and proactively contact OmniSource (877-456-6794) on day 10 to initiate bridge supply. This prevents even a single missed dose for your patient.
Program 4: Novartis Patient Assistance Program — Cost-Free for Eligible Patients
For income-eligible patients who are uninsured or underinsured, the Novartis Patient Assistance Program can provide Omnitrope at no cost. Income thresholds apply. Your office staff or the OmniSource team can help determine eligibility. Contact OmniSource or visit novartis.com for current eligibility criteria.
Program 5: Good Days Patient Assistance — For Insured Patients with Financial Need
Good Days (mygooddays.org, 1-877-968-7233) offers additional financial assistance for patients who have insurance that covers Omnitrope but still face unaffordable cost-sharing. Eligibility is income-based. This can supplement the OmniSource Co-Pay Program in cases where the savings card alone does not bring costs to a manageable level.
Medicare Part D Patients: Special Considerations
Manufacturer co-pay programs cannot be used with Medicare Part D. However, Medicare Part D's 2026 annual out-of-pocket cap of $2,100 is significant. Once a patient reaches this threshold, the plan pays 100% for the rest of the year. For Medicare patients with high growth hormone costs, front-loading treatment early in the calendar year (if clinically appropriate) can get them past the cap sooner. The Medicare Prescription Payment Plan also allows patients to spread out-of-pocket costs evenly across the year rather than paying a large amount early.
Recommended Office Workflow for Omnitrope Savings
- At time of prescription: Confirm insurance status; enroll commercially insured patients in the Co-Pay Savings Program; route uninsured patients to the Self-Pay Program; submit PA with complete documentation.
- Day 10 of PA pending: If insurance hasn't approved yet, call OmniSource (877-456-6794) to initiate bridge supply. Patient should not wait until they've run out.
- At PA denial: Initiate appeal with complete clinical documentation. Activate bridge supply if available. Consider therapeutic substitution to formulary-preferred brand as backup.
- At PA renewal (annual): Submit renewal 30 days before expiration. Confirm savings card is still active (these may require annual re-enrollment).
How medfinder Reduces Your Practice's Access-Related Phone Volume
When patients can't find Omnitrope at their pharmacy, they call your office. medfinder calls pharmacies near the patient to check stock and texts results to them directly — significantly reducing the time your front-desk and nursing staff spend fielding "my pharmacy doesn't have it" calls. Directing patients to medfinder is a simple, high-leverage step you can add to your patient education materials. Learn more at medfinder.com/providers.
Key Contacts for Omnitrope Patient Support
- OmniSource (all programs): 877-456-6794 | omnitrope.com
- Co-Pay Savings Program: 1-866-954-5512 | omnitrope.com/co-pay-savings-program
- Good Days: 1-877-968-7233 | mygooddays.org
- medfinder (pharmacy locator): medfinder.com/providers
Frequently Asked Questions
Sandoz's OmniSource program (877-456-6794) offers four main programs: (1) Co-Pay Savings Program — as low as $0/month for commercially insured patients; (2) Self-Pay Program — $19/mg for uninsured or uncovered patients; (3) Bridge Supply — free Omnitrope for up to 1 year if insurance is delayed >10 days; (4) Interim Assistance. The Novartis Patient Assistance Program provides free medication for income-eligible uninsured patients.
No. Manufacturer co-pay programs cannot be combined with Medicare Part D coverage. However, Medicare Part D's 2026 annual out-of-pocket cap of $2,100 means that once that threshold is met, the plan pays 100% for the rest of the year. Good Days (mygooddays.org) may be able to provide additional assistance for Medicare patients with financial need.
Contact OmniSource at 877-456-6794. The program is available for uninsured patients and commercially insured patients whose insurance does not cover Omnitrope. Patients receive Omnitrope Pen 5 and Pen 10 at $19/mg. Enrollment can be initiated by the patient or by your office staff on their behalf.
OmniSource typically needs: the patient's name and contact information, insurance plan and policy number, the date the PA was submitted, documentation that 10+ business days have passed without approval, and the prescribing physician's information. Your office's PA coordinator can often initiate this call on the patient's behalf.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Omnitrope also looked for:
More about Omnitrope
36,651 have already found their meds with Medfinder.
Start your search today.





